INTRAVENOUS REGIONAL ANESTHESIA WITH KETOROLAC-LIDOCAINE FOR THE MANAGEMENT OF SYMPATHETICALLY-MEDIATED PAIN

Citation
Nr. Connelly et al., INTRAVENOUS REGIONAL ANESTHESIA WITH KETOROLAC-LIDOCAINE FOR THE MANAGEMENT OF SYMPATHETICALLY-MEDIATED PAIN, The Yale journal of biology & medicine, 68(3-4), 1995, pp. 95-99
Citations number
14
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
0044-0086
Volume
68
Issue
3-4
Year of publication
1995
Pages
95 - 99
Database
ISI
SICI code
0044-0086(1995)68:3-4<95:IRAWKF>2.0.ZU;2-W
Abstract
This retrospective study was undertaken to determine the usefulness of intravenous regional anesthetic (IVRA) blocks containing ketorolac an d lidocaine in the management of sympathetically-mediated pain, and to determine what factors, if any, predicted success with this technique . Sixty-one patients with reflex sympathetic dystrophy presenting to a university-affiliate teaching hospital's pain management center were evaluated. Patients underwent one or more treatments with IVRA blocks containing ketorolac and lidocaine. The duration of pain, site of extr emity affected, pain symptomatology, duration of relief from the first IVRA block, absence of pain following a series of IVRA blocks and sid e-effects from the IVRA blocks were determined. Of the 61 patients, 16 had complete response (26 percent), 26 had a partial response (43 per cent) and 19 had no response (31 percent) to the ketorolac-containing IVRA. The only symptom which predicted a failure with this therapy was allodynia. No patient had serious side effects from the IVRA block; d izziness following tourniquet release occurred in 41 percent (n = 25) of the patients. IVRA block containing ketorolac is a useful and minim ally invasive technique for the management of patients with reflex sym pathetic dystrophy.